Search the Newsreel

Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses

Parnassus Investments, an investment management company, released the "Parnassus Core Equity Fund" second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500's 15.20% gain. Performance …

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these …

Here’s What Hurt Boston Scientific Corporation (BSX) in Q2

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve …

Boston Scientific Director Habiger Buys $100k of Shares Amid 54% Decline. What Does This Mean for BSX in 2026?

David C. Habiger, a Director at Boston Scientific Corporation (NYSE:BSX), purchased 2,100 shares of Common Stock on August 5, 2026, according to an SEC Form 4 filing. Transaction summary Metric Value Shares purchased 2,100 Transaction value $99,939 Post-transaction shares (directly held) 17,160 Post-transaction value …

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corporation (NYSE:BSX), purchased 186,240 shares of common stock at $48.34 per share on August 3, 2026. SEC Form 4 filing. Transaction summary Metric Value Transaction value $10.1 million Shares purchased 208,359 Post-transaction shares (total) …

Notícias das Ações da Boston Scientific Corp (BSX)

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air …

Projeções de Resultados: Boston Scientific Corp (BSX) — LPA e Crescimento de Receita

Bear of the Day: Boston Scientific (BSX)

Boston Scientific (BSX) manufactures medical devices and products used in various interventional medical specialties worldwide, including cardiovascular and surgical categories. On July 29, BSX reported revenue of $5.44 billion for their June quarter, up 7.5% over the same period last year. EPS came in …

Tuesday 8/4 Insider Buying Report: BSX, CMCO

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Boston Scientific, a filing with the …

BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook

BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q2 CY2026, with sales up 7.5% year on year to $5.44 billion. On the other hand, next quarter's revenue guidance of $5.27 billion …

Por que as ações da Boston Scientific estão caindo hoje? - Investing.com Brasil

What Boston Scientific’s Q2 Earnings Reveal About the EP Market’s New Competition

BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure

Boston Scientific Corporation BSX delivered a solid second quarter, but management highlighted a tougher path ahead as pressure in WATCHMAN and electrophysiology changed the company's near-term outlook. Executives reduced full-year expectations while emphasizing cost actions and future product catalysts. The call focused on market …

What Are Wall Street Analysts' Target Price for Boston Scientific Stock?

Boston Scientific sign at manufacturer of medical devices Silicon Valley office By MichaelVi Marlborough, Massachusetts-based Boston Scientific Corporation (BSX) is a global medical technology company that develops, manufactures, and markets minimally invasive medical devices. With a market capitalization of approximately $68.5 billion, the company …

Boston Scientific (BSX) Stock Sees Modest Fair Value Cut As Watchman Concerns Reset Expectations

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Analyst fair value for Boston Scientific has shifted from US$75.00 to US$72.25, pointing to a modest reset in price targets. This change lines up with recent research …

Boston Scientific beats second quarter expectations, raises full-year outlook

Boston Scientific beats second quarter expectations, raises full-year outlook Proactive uses images sourced from Shutterstock Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while raising its full-year sales outlook. The medical device company posted …

Boston Scientific reports positive Q2 results yet opts to trim 2026 outlook

Boston Scientific has reported Q2 revenues of around $5.4bn, indicative of a 7.5% year-over-year (YoY) rise, yet has elected to trim its full-year outlook. The lion's share of Boston's revenues came from its cardiovascular segment at around $3.6bn, indicative of an 8.3% YoY uplift …

Boston Scientific (BSX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Boston Scientific (BSX) reported revenue of $5.44 billion, up 7.5% over the same period last year. EPS came in at $0.86, compared to $0.75 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Boston Scientific Beats Second-Quarter Expectations as Sales Growth Lifts Shares

Woman looking through microscope ©The U.S. National Archives Boston Scientific (NYSE:BSX) shares rose more than 3% in pre-market trading on Wednesday after the medical device manufacturer reported second-quarter earnings and revenue that exceeded Wall Street expectations, supported by broad-based growth across its business. The …

Boston Scientific again cuts 2026 guidance

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers Q2 sales: $5.44 billion 7.5% growth year over year Net income: $907 million Compared with $797 million in Q2 …

Boston Scientific trims annual profit forecast on softer Watchman device demand

July 29 (Reuters) - Medical device maker Boston Scientific on Wednesday lowered its annual profit forecast, citing pressure on its Watchman heart ‌device business. The company, in May, warned of pressure on its ‌Watchman heart device, a small implant used to help prevent stroke-causing …

Boston Scientific Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - Boston Scientific Corp (BSX) will host a conference call at 8:00 AM ET on July 29, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.bostonscientific.com/events-and-presentations The views and opinions expressed herein are the views and …

Boston Scientific Q2 2026 Earnings Preview

* Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) is scheduled to announce Q2 earnings results on Wednesday, July 29th, before market open. * The consensus EPS Estimate is $0.83 [https://seekingalpha.com/symbol/BSX/earnings/estimates] (+10.7% Y/Y) and the consensus revenue estimate is $5.37B (+6.1% Y/Y). * Over the last 2 years, …

Canaccord mantém recomendação de compra para ações da Boston Scientific após reestruturação - Investing.com Brasil

What To Expect From Boston Scientific’s (BSX) Q2 Earnings

What To Expect From Boston Scientific's (BSX) Q2 Earnings Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday morning. Here's what to expect. Boston Scientific beat analysts' revenue expectations last quarter, reporting revenues of $5.20 billion, up 11.6% year on year. …

Boston Scientific Restructuring To Trim Workforce

(RTTNews) - Boston Scientific Corp (BSX) has unveiled a sweeping global restructuring program, according to its Form 8-K filing with the U.S. Securities and Exchange Commission. The plan, approved by the board of directors, is designed to streamline operations, optimize supply chains, and align …

Boston Scientific unveils new restructuring plan, expects job cuts

July 27 (Reuters) - Boston Scientific's board has approved a new company-wide restructuring plan aimed at ‌cutting costs and to better position the ‌company for future growth, the medical device maker said in a ​regulatory filing on Monday. Here are some details: • The …

Boston Scientific percutaneous catheters focus of FDA safety alert

[Nurse opening sterile package containing iv catheter in hospital setting] Carmen Ruiz alonso/iStock via Getty Images * The US FDA is recommending that certain lots of Boston Scientific's (BSX [https://seekingalpha.com/symbol/BSX]) ENROUTE Transcarotid Neuroprotection System percutaneous catheters be avoided following reports of arterial sheath tip …